Chad Oh - 17 Feb 2026 Form 4 Insider Report for AEON Biopharma, Inc. (AEON)

Role: CHIEF MEDICAL OFFICER
Signature: /s/ Alexander Wilson, as Attorney-in-Fact, for Chad Oh
Issuer symbol: AEON
Transactions as of: 17 Feb 2026
Net transactions value: $0
Form type: 4
Filing time: 11 Mar 2026, 20:13:33 UTC
Previous filing: 23 May 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Oh Chad	CHIEF MEDICAL OFFICER	C/O AEON BIOPHARMA, INC., 5 PARK PLAZA, SUITE 1750, IRVINE	/s/ Alexander Wilson, as Attorney-in-Fact, for Chad Oh	11 Mar 2026	0001882166

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AEON	Class A Common Stock	Award		+862,500	+21223%	$0.000000^*	866,564	17 Feb 2026	Direct	F1
transaction	AEON	Class A Common Stock	Award		+1,316,872	+152%	$0.000000^*	2,183,436	04 Mar 2026	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents an award of restricted stock units granted on February 17, 2026 (the "Grant Date"), which vest in substantially equal installments on each of the first, second, third and fourth anniversary of the Grant Date, subject to continued service through the applicable vesting date.
F2	Represents outstanding cash-settled restricted stock units granted on May 21, 2025 (the "Grant Date") that were modified on March 4, 2026 to be settled in stock instead of cash upon vesting. The restricted stock units continue to vest in substantially equal installments on each of the first, second, third and fourth anniversary of the Grant Date, subject to continued service through the applicable vesting date. The restricted stock units were originally reported in Table II on a Form 4 filed on May 23, 2025.

Content

Represents an award of restricted stock units granted on February 17, 2026 (the "Grant Date"), which vest in substantially equal installments on each of the first, second, third and fourth anniversary of the Grant Date, subject to continued service through the applicable vesting date.

Represents outstanding cash-settled restricted stock units granted on May 21, 2025 (the "Grant Date") that were modified on March 4, 2026 to be settled in stock instead of cash upon vesting. The restricted stock units continue to vest in substantially equal installments on each of the first, second, third and fourth anniversary of the Grant Date, subject to continued service through the applicable vesting date. The restricted stock units were originally reported in Table II on a Form 4 filed on May 23, 2025.